Efficacy of EGb761 in Patients Suffering From Friedreich Ataxia

Clinical trial NCT00824512 · COMPLETED

Trial details

NCT number: NCT00824512
Sponsor: Ipsen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Friedreich Ataxia

Start date: 2008-06-01
Primary completion: 2011-10-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.